Cargando…

Cup‐like blasts in acute myeloid leukaemia with NPM1 and IDH2 mutations

Detalles Bibliográficos
Autores principales:	Ohya, Eiko, Sugimoto, Yuka, Sasao, Ryota, Nishimura, Misa, Mizutani, Minoru, Sekine, Takao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Haematology Images
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175697/ https://www.ncbi.nlm.nih.gov/pubmed/35844705 http://dx.doi.org/10.1002/jha2.200

Ejemplares similares

The value of molecular stratification for CEBPA (DM) and NPM1 (MUT) FLT3 (WT) genotypes in older patients with acute myeloid leukaemia
por: Dickson, Glenda J., et al.
Publicado: (2015)

Colonic myeloid sarcoma with mutated NPM1 manifesting with ulceration
por: Tashakori, Mehrnoosh, et al.
Publicado: (2022)

Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low‐intensity chemotherapy in acute myeloid leukaemia
por: Tiong, Ing S., et al.
Publicado: (2020)

Chronic myeloid leukaemia with marked thrombocytosis
por: Ooi, Jun, et al.
Publicado: (2020)

Cup‐like blasts in an adult patient with BCR‐ABL1 positive B‐cell acute lymphoblastic leukemia
por: Wang, Zhenni, et al.
Publicado: (2022)

Two ophthalmic presentations of chronic myeloid leukaemia
por: Kiernan, Miles, et al.
Publicado: (2022)

Phlegmonous gastritis as the initial presentation of acute myeloid leukaemia
por: Lee, Shin, et al.
Publicado: (2022)

Therapy related acute myeloid leukemia with blast cannibalism and cytophagocytosis
por: Moshref Razavi, Habib, et al.
Publicado: (2020)

Hemophagocytosis by acute myeloid leukemia blasts associated to poor clinical outcomes
por: Ouedraogo, Zangbéwendé Guy, et al.
Publicado: (2022)

Acute myeloid leukaemia: challenges and real world data from India
por: Philip, Chepsy, et al.
Publicado: (2015)

Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia
por: Cressman, Sonya, et al.
Publicado: (2016)

Roth spots and retinal haemorrhages as initial presentations of chronic myeloid leukaemia
por: Jacob, Nkemdirim, et al.
Publicado: (2021)

Acute myeloid leukaemia with aberrant expression of pancytokeratin: A diagnostic pitfall
por: Dhonye, Yasin, et al.
Publicado: (2022)

Blast phase of chronic myeloid leukemia presenting as early T‐cell precursor lymphoblastic leukemia
por: Qiu, Lianqun, et al.
Publicado: (2021)

Development of JAK2 positive myelofibrosis on a background of chronic myeloid leukaemia
por: Mullen, Christopher Gerard, et al.
Publicado: (2022)

Clinical significance of nuclear non-phosphorylated beta-catenin in acute myeloid leukaemia and myelodysplastic syndrome
por: Xu, Jinglan, et al.
Publicado: (2008)

Unusual CD34 positivity in acute myeloid leukaemia with myelodysplasia‐related changes with megakaryoblastic differentiation
por: Avenoso, Daniele, et al.
Publicado: (2021)

Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome
por: Ohya, Eiko, et al.
Publicado: (2016)

Nilotinib dose‐optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd
por: Hughes, Timothy P., et al.
Publicado: (2017)

The presence of Auer rods in neutrophils and monocytes besides blasts in a case of acute myeloid leukemia with CSF3R mutation
por: Koziol, Haley, et al.
Publicado: (2022)

Factors influencing long‐term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib
por: Brümmendorf, Tim H., et al.
Publicado: (2015)

Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial
por: Brümmendorf, Tim H, et al.
Publicado: (2015)

Chronic Myeloid Leukaemia with isolated massive thrombocytosis and BCR‐ABL1 detection failure using RT‐MLPA (positive RT‐qPCR)
por: Coster, Lucie, et al.
Publicado: (2021)

Identification of seasonal variation in the diagnosis of acute myeloid leukaemia: a population‐based study
por: Sánchez‐Vizcaíno, Fernando, et al.
Publicado: (2022)

Wilms’ Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses
por: Uttenthal, Benjamin, et al.
Publicado: (2014)

REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia
por: Stuart, Robert K, et al.
Publicado: (2015)

A 4‐gene expression score associated with high levels of Wilms Tumor‐1 (WT1) expression is an adverse prognostic factor in acute myeloid leukaemia
por: Niavarani, Ahmadreza, et al.
Publicado: (2016)

Plasmablastic myeloma progressed to plasma cell leukaemia
por: Xu, Ke, et al.
Publicado: (2021)

Burkitt leukaemia with B‐cell precursor immunophenotype
por: Xu, Ke, et al.
Publicado: (2022)

Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi‐centre setting
por: Hanekamp, Diana, et al.
Publicado: (2020)

Transformation of myelodysplastic syndrome to mixed phenotype acute leukaemia
por: Do, Louis, et al.
Publicado: (2020)

Primary plasma cell leukaemia presenting as unilateral proptosis
por: Schrijver, Irene T., et al.
Publicado: (2023)

New Quantitative Method to Identify NPM1 Mutations in Acute Myeloid Leukaemia
por: Huet, Sarah, et al.
Publicado: (2013)

Preferential transcription of the mutated allele in NPM1 mutated acute myeloid leukaemia
por: Bailey, G. D., et al.
Publicado: (2020)

Identification of FLT3 and NPM1 Mutations in Patients with Acute Myeloid Leukaemia
por: Yusoff, Yuslina Mat, et al.
Publicado: (2019)

Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation
por: Chin, Lynn, et al.
Publicado: (2023)

Megakaryoblasts in pleural fluid in neonate with transient leukaemia of Down's syndrome
por: Chmielowiec, Karolina, et al.
Publicado: (2023)

The prognostic effect of smoking status on intensively treated acute myeloid leukaemia – A Danish nationwide cohort study
por: Kristensen, Daniel, et al.
Publicado: (2020)

Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T‐cell phenotype
por: Harrington, Patrick, et al.
Publicado: (2022)

Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia: A Danish nationwide cohort study
por: Kristensen, Daniel Tuyet, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sjmp0500pjvlf0q9d0k1qlljop